Pfizer spin-out RaQualia heads towards delayed Japanese IPO
This article was originally published in Scrip
Executive Summary
RaQualia Pharma's plans for an IPO in Japan are moving ahead after being postponed following the devastating 11 March earthquake and tsunami, with its shares due to start trading on the Osaka Stock Exchange's Jasdaq market on 20 July.